Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30

$2.10−0.02 (-0.94%)

Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –

Compugen gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 87.3%, against 71.5% the year before. The highest annual figure on record is 100.0% in fiscal 2009.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	87.3%	+15.7
FY2024	Dec 31, 2024	71.5%	−22.5
FY2023	Dec 31, 2023	94.0%	+7.0
FY2022	Dec 31, 2022	87.0%	−1.7
FY2021	Dec 31, 2021	88.7%	−8.3
FY2020	Dec 31, 2020	97.0%	+2.8
FY2018	Dec 31, 2018	94.2%	+25.5
FY2016	Dec 31, 2016	68.7%	−13.7
FY2015	Dec 31, 2015	82.4%	+9.4
FY2014	Dec 31, 2014	73.0%	+43.7
FY2013	Dec 31, 2013	29.3%	+12.4
FY2012	Dec 31, 2012	16.9%	−63.0
FY2010	Dec 31, 2010	79.9%	−20.1
FY2009	Dec 31, 2009	100.0%	–